FLOXURIDINE Side Effects

6635361-6 | Cerebellar Ataxia, Thrombocytopenia
on Mar 11, 2010 Female patient from UNITED STATES , 49 years of age, weighting 127.9 lb, was diagnosed with pancreatic carcinoma and was treated with Floxuridine (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar ataxia, thrombocytopenia. Floxuridine dosage: 1,1360 Mg 5 Days Iv Bolus.

5933854-8 | Diabetes Mellitus Inadequate Control, Infection, Sepsis, Unresponsive To Stimuli
Patient was taking Floxuridine (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, infection (What is infection?), sepsis (What is sepsis?), unresponsive to stimuli on Oct 13, 2008 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with oesophageal adenocarcinoma and. Floxuridine dosage: . Patient was hospitalized.

5933852-4 | Diarrhoea, Neutropenia
Adverse event was reported on Oct 13, 2008 by a Male patient taking Floxuridine (View Usage) (Dosage: ) was diagnosed with oesophageal adenocarcinoma and. Location: UNITED STATES , 63 years of age, After Floxuridine was administered, patient had the following side effects: diarrhoea, neutropenia. Patient was hospitalized.

5933851-2 | Abdominal Pain Upper, Febrile Neutropenia, Haematemesis, Nausea, Oesophageal Perforation, Oesophageal Stent Insertion, Procedural Complication
on Oct 13, 2008 Male patient from UNITED STATES , 80 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with Floxuridine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, febrile neutropenia, haematemesis, nausea (What is nausea?), oesophageal perforation, oesophageal stent insertion, procedural complication. Floxuridine dosage: . Patient was hospitalized.


5445732-1 | Dyspnoea, Haematocrit Increased, Haemoglobin Increased, Pulmonary Arteriovenous Fistula, Tachycardia
on Aug 23, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with metastases to lung and was treated with Floxuridine (View Usage). Patient had the following side effects: dyspnoea, haematocrit increased, haemoglobin increased, pulmonary arteriovenous fistula, tachycardia. Floxuridine dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ALPHA INTERFERON (View Alpha-interferon Review and Alpha-interferon Label ), ALPHA INTERFERON (View Alpha-interferon Review and Alpha-interferon Label ), GEMCITABINE HCL (View Gemcitabine Hcl Review and Gemcitabine Hcl Label ), CAPECITABINE (View Capecitabine Review and Capecitabine Label ).

5402053-0 | Arteriovenous Malformation, Blood Erythropoietin Increased, Haematocrit Increased, Haemoglobin Increased, Mixed Venous Blood Saturation Decreased, Oxygen Saturation Decreased, Tachycardia
Patient was taking Floxuridine (View Usage). After Floxuridine was administered, patient had the following side effects: arteriovenous malformation (What is arteriovenous malformation?), blood erythropoietin increased, haematocrit increased, haemoglobin increased, mixed venous blood saturation decreased, oxygen saturation decreased, tachycardia on Jul 17, 2007 from UNITED STATES Additional patient health information: Female patient , 73 years of age, was diagnosed with metastases to lung and. Floxuridine dosage: . Patient was hospitalized.

5016566-7 | Hepatic Enzyme Increased
Adverse event was reported on Feb 13, 2006 by a Female patient taking Floxuridine (View Usage) (Dosage: 6400mg/iv/once Weekly For 3 W) was diagnosed with pancreatic carcinoma and. Location: UNITED STATES , 58 years of age, Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased.

4704109-4 | Abasia, Catheter Related Complication, Gastric Ulcer, Pain In Extremity, Palmar-plantar Erythrodysaesthesia Syndrome
on Jun 23, 2005 Male patient from , 36 years of age, was diagnosed with colon cancer and was treated with Floxuridine (View Usage). Patient had the following side effects: abasia, catheter related complication, gastric ulcer, pain in extremity, palmar-plantar erythrodysaesthesia syndrome. Floxuridine dosage: 0.25 Mg/kg Ia. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), HEPARIN (View Heparin Review and Heparin Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ). Patient was hospitalized.

4644591-4 | Hepatic Enzyme Abnormal, Jaundice
on Apr 25, 2005 Male patient from , 48 years of age, was treated with Floxuridine (View Usage). After Floxuridine was administered, patient had the following side effects: hepatic enzyme abnormal, jaundice (What is jaundice?). Floxuridine dosage: . Patient was hospitalized.